期刊文献+

肾上腺髓质素在先天性心脏病中的测定及临床意义 被引量:3

Plasma levels of adrenomedullin in children with congenital heart disease
在线阅读 下载PDF
导出
摘要 目的肾上腺髓质素(ADM)对心血管疾病有多方面的影响,但其与先天性心脏病关系的研究较少。该实验通过检测不同类型先天性心脏病患儿体内ADM的变化,分析ADM在先天性心脏病病理生理中的作用。方法筛选住院的48例先天性心脏病患儿,经超声心动图及心导管检查术证实,在心导管检查术中测定血流动力学指数及采血备测,依据血流动力学特征分为高肺血流非肺动脉高压组、高肺血流并肺动脉高压组、紫绀组,平均肺动脉压(mPAP)>20 mmHg为肺动脉高压的标准。选6例川崎病痊愈患儿作为对照组。采用特异性放射免疫法检测血浆ADM的水平。结果先天性心脏病患儿股静脉中的血浆ADM水平较股动脉明显增高(P<0.05);与对照组相比,高肺血流并肺高压组及紫绀组中的ADM明显增高,均P<0.01;ADM与主动脉平均压(mSAP)、混合静脉血氧饱和度(MVsat)、主动脉血氧饱和度(AOsat)及肺血管阻力(Rp)之间有密切的关系。结论高肺血流并肺动脉高压和紫绀型先天性心脏病患儿的ADM水平增高,ADM的变化同肺动脉阻力和缺氧有密切关系,推测ADM水平的升高可能有助于减轻肺动脉阻力和改善缺氧。 Objective This study was designed to investigate the pathophysiological role of adrenomedullin (ADM) in congenital heart disease. Methods Forty-eight children with congenital heart disease confirmed by cardiac echocardiography and catheterization were studied. The patients were divided into three groups on the basis of hemodynamic indices measured during cardiac catheterization: high pulmonary blood flow with ( group 1 ) or without ( group 2 ) pulmonary hypertension (mean pulmonary arterial pressure 〉 20 mmHg) and a cyanosis group (without high pulmonary blood flow) ( group 3 ). Six children who recovered from Kawasaki disease were used as a Control group. Plasma ADM levels were measured by radioimmunoassay. Results The plasma ADM levels from the femoral vein were significantly higher than those from femoral artery in patients with congenital heart disease. The patients from group 1 and group 3 had higher plasma ADM levels ( 1.9 + 1.8 pmol/L and 2.4 + 1.3 pmol/L, respectively) than the controls ( 1.0±1.4 pmol/L; P 〈0.01 ). Plasma ADM levels were significantly negatively correlated with mean systemic arterial pressure, oxygen saturation in mixed vein and oxygen saturation in systemic artery ( r=-0. 401, -0. 562, -0. 600, respectively ; P 〈 0. 01 ) but positively correlated with pulmonary vascular resistance ( r = 0. 406 ; P 〈 0.01 ). Conclusions Plasma ADM levels are increased in congenital heart disease with high pulmonary blood flow and hypertension or with cyanosis. Plasma ADM levels are related to pulmonary arterial resistance and hypoxemia. Increased ADM levels may play roles in reducing the pulmonary arterial resistance and alleviating hypoxemia in these patients.
出处 《中国当代儿科杂志》 CAS CSCD 2006年第2期90-92,共3页 Chinese Journal of Contemporary Pediatrics
关键词 肾上腺髓质素 先天性心脏病 肺动脉高压 缺氧 Adrenomedullin Congenital heart disease Hypertension, pulmonary Hypoxemia
作者简介 朱晓波,男,硕士,医师。主攻方向:心血管疾病。 [通讯作者]王一彪,教授,山东大学第二医院儿内科,邮编:250033。
  • 相关文献

参考文献10

  • 1Kitamura K,Kangawa K,Kawamoto M,Ichiki Y,Nakamura S,Matsuo H,et al.Adrenomedullin:A novel hypotensive peptide isolated from human pheochromocytoma[J].Biochem Biophys Res Commun,1993,192(2):553-560.
  • 2Ishimitsu T,Nishikimi T,Saito Y,Kitamura K,Eto T,Kangawa K,et al.Plasma levels of adrenomedullin,a newly identified hypotensive peptide,in patients with hypertension and renal failure[J].J Clin Invest,1994,94(5):2158-2161.
  • 3Kakishita M,Nishikimi T,Okano Y,Satoh T,Kyotani S,Nagaya N,et al.Increased plasma levels of adrenomedullin in patients with pulmonary hypertension[J].Clin Sci,1999,96 (1):33-39.
  • 4Beltowski J,Jadmroz A.Adrenomedullin-what do we know 10years since its discovery?[J].Pol J Pharmacol,2004,56(1):5-27.
  • 5McGregor DO,Troughton RW,Frampton C,Lynn KL,Yandle T,Richards AM,et al.Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment[J].Hypertension,2001,37 (5):1279-1284.
  • 6Nagaya N,Satoh T,Nishikimi T,Uematsu M,Furuichi S,Sakamaki F.Hemodynamic,renal,and hormonal effects of adrenomedullin infusion in patients with congestive heart failure[J].Circulation,2000,101 (5):498-503.
  • 7李筠,周爱卿.先天性心脏病肺高压肺血管功能与结构的改变[J].中国当代儿科杂志,2001,3(3):212-214. 被引量:6
  • 8卢慧玲,陈绍军.肾上腺髓质素在左向右分流型先天性心脏病合并肺动脉高压中的作用[J].中华儿科杂志,2002,40(10):598-601. 被引量:8
  • 9Cormier-Regard S,Nguyen SV,Claycomb WC.Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes[J].J Biol Chem,1998,273 (28):17787-17792.
  • 10Nagaya N,Nishikimi T,Uematsu M,Satoh T,Oya H Kyotani S,et al.Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension[J].Heart,2000,84(6):653-658.

二级参考文献14

  • 1Rabinnovitch M, Bothwell T, Hayakawa BN, et al. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: a correlation of light with scanning electron microscopy and transmission electron microscopy[J]. Lab Invest, 1986, 55(2): 632-653.
  • 2Adatia I, Barrow SE, Stratton PD, et al. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease [J]. Circulation, 1993, 88(5): 2117-2122.
  • 3Lerman A, Hildebrand FL, Aarhus LL, et al. Endothelin has biological actions at pathophysiological concentrations [J]. Circulation, 1991, 83(5): 1808-1814.
  • 4Vender RL, Clemmons DR, Kwock L, et al. Reduced oxygen tension induces pulmonary endothelium to release a pulmonarysmood muscle cell mitogens[J]. Am Rev Respir Dis, 1987, 135(3): 622-627.
  • 5Penny WF, Weinstein M, Salzman EW, et al. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics [J]. Circulation, 1991, 83(5): 1630-1636.
  • 6Kitamura K,Kangwa K,Kawamoto M,et al.Adrenomedatllin: a novel hypertension peptide isolated from human pheochromocytoma[].Biochemical and Biophysical Research Communications.1993
  • 7Shimokubo T,Sakata J,Kitamura K,et al.Augment adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension[].Life Sciences.1995
  • 8Michihisa J,Chiming W,Linda J,et al.Elevation of circulating and ventricular adrenomedullin in human congestive heart failure[].Circulation.1995
  • 9Ishikawa S,Miyauchi T,Sakai S,et al.Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair[].Journal of Thoracic and Cardiovascular Surgery.1995
  • 10Kano H,Kohno M,Yasunari K,et al.Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cell[].Journal of Hypertension.1996

共引文献12

同被引文献24

  • 1钟萍,李志樑,唐朝枢.充血性心力衰竭患者血管活性物质变化的临床意义[J].中国实用内科杂志,2005,25(1):27-29. 被引量:23
  • 2刘海潮,刘映峰,李志樑,李公信,叶文胜,魏向荣,赵霞,唐朝枢.PCI术对冠状动脉循环中肾上腺髓质素及内皮素的影响[J].心肺血管病杂志,2004,23(4):213-215. 被引量:4
  • 3李利华,李燕,王继光.肾上腺髓质素与心血管疾病[J].心血管病学进展,2005,26(3):322-324. 被引量:3
  • 4丁亚光,齐建光,杜军保,唐朝枢.通过微量渗透泵应用肾上腺髓质素对大鼠低氧性肺动脉高压的调节作用[J].实用儿科临床杂志,2005,20(7):628-629. 被引量:8
  • 5王慕逖.儿科学[M].5版.北京:人民卫生出版社,2001:108.
  • 6Gegenhuber A, Struck J, Dieplinger B, et al. Comparative evaluation of B - type natriuretic peptide, mid - regional pro - A - type natriuretic peptide, mid - regional pro - adrenomedullin, and copeptin to predict 1 - year mortality in patients with acute destabilized heart failure [ J ]. J Card Fail,2007,13 ( 1 ) :42 -49.
  • 7Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma [ J ]. Biochem Biophys Res Commun,1993 ,192( 2 ) :533 -560.
  • 8Ishimitsu T, Ono H, Minami J, et al. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders [ J ]. Pharmacol Ther,2006,111 (3) :909 -927.
  • 9Yanagawa B, Nagaya N. Adrenomedullin:Molecular mechanisms and its role in cardiac disease[ J]. Amino Acids ,2007,32( 1 ) : 157 - 164.
  • 10Parker JD ,Thiessen JJ. Increased endothelin -1 production in patients with chronic heart failure[ J]. Am J Physiol Heart Circ Physiol,2004,286(3) :1141 - 1145.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部